Package Inserts: Influenza (H1N1)

Links shared publicly online about this topic.

  • 1,039
    total visits

Package Inserts: Influenza (H1N1)

immunize.org

Package Inserts: Influenza (H1N1)

View full resource at immunize.org

Tags: Vaccination, Flu, H1N1, Vaccine

  • Share

Most Recently Shared on July 7, 2010 at 11:30 pm By:

mercola Dr. Mercola

Here's a helpful page where you can find package inserts for many of the most common vaccines, including those for H1N1. http://ow.ly/26Zlc

2 years ago...

Sittercity partners with Bright Horizons Family Solutions to create a Corporate Program

news-medical.net — “Sittercity Inc, America's first and largest online source for connecting parents and sitters has partnered with Bright Horizons Family Solutions, the world's leading provider of employer-sponsored child care, back-up care, education, and work/life solutions to create a program that allows employers to offer their employees access to Sittercity as part of their work/life benefits package.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on October 23, 2009 at 9:57 pm By:

H1_N1_Swine_flu News-Medical.Net Health News

H1N1 Swine Flu News: Sittercity partners with Bright Horizons Family Solutions to create a .. http://twurl.nl/kgzt68

2 years ago...

FDA grants Response Biomedical a Special 510(k) clearance for the RAMP Influenza A/B Assay

news-medical.net — “Response Biomedical Corporation announced that the Company has been granted a Special 510(k) U.S. FDA clearance for an update to the Company's RAMP® Influenza A/B Assay Package Insert to include analytical reactivity information for a strain of the 2009 H1N1 virus cultured from positive respiratory specimens.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on October 22, 2009 at 4:57 pm By:

H1_N1_Swine_flu News-Medical.Net Health News

H1N1 Swine Flu News: FDA grants Response Biomedical a Special 510(k) clearance for the RAMP.. http://twurl.nl/2vo26r

2 years ago...

AVI BioPharma receives $11.5M DTRA fund to develop AVI-7012 for treating Junin virus infection

news-medical.net — “AVI BioPharma, Inc. a developer of RNA-based drugs, announced today that it has received expanded contract funding of approximately $11.5 million from the Defense Threat Reduction Agency's (DTRA) Transformational Medical Technologies Initiative (TMTI) to support development of the Investigational New Drug (IND) data package for its candidate drug, AVI-7012, to treat Junin virus infection.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on October 5, 2009 at 7:10 pm By:

H1_N1_Swine_flu News-Medical.Net Health News

H1N1 Swine Flu News: AVI BioPharma receives $11.5M DTRA fund to develop AVI-7012 for treati.. http://twurl.nl/x06sgr

3 years ago...

H1N1 Swine Flu Vaccine Insert Admits It Causes Guillain-Barre Syndrome, Vasculitis, Paralysis, Anaphylactic Shock And Death

prisonplanet.com — “The package insert for the Influenza A (H1N1) 2009 Monovalent Vaccine manufactured by Novartis has been leaked on the Internet.View full resource at prisonplanet.com

  • View Related
  • Share

Most Recently Shared on September 29, 2009 at 1:45 pm By:

Vita_Hive Vitamin News Health News

H1N1 Swine Flu Vaccine Insert Admits It Causes Guillain-Barre ... http://bit.ly/ktfXD

3 years ago...

Meridian Granted Special 510(k) Clearance To Add 2009 H1N1 Influenza A Virus Analytical Sensitivity Claim To The TRU FLU(R) Test Package Insert

medicalnewstoday.com — “Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) announced that the company has been granted a Special 510(k) clearance to update the TRU FLU package insert to include analytical sensitivView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 20, 2009 at 12:00 pm By:

mnt_swineflu MNT Swine Flu News Health News

Meridian Granted Special 510(k) Clearance To Add 2009 H1N1 Influenza A Virus Analytical Sensitivity Claim To The.. http://bit.ly/1j6Uad

3 years ago...

Quidel's QuickVue Influenza A+B test receives special 510(k) clearance for H1N1 reactivity update

news-medical.net — “Quidel Corporation (NASDAQ: QDEL), a global leader in point-of-care (POC) rapid diagnostic tests, received Special 510(k) clearance for an update to the Company's QuickVue® Influenza A+B test package insert to include reactivity with culture isolates of the 2009 H1N1 Influenza A virus.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on September 17, 2009 at 7:06 pm By:

Oncology_News News-Medical.Net Oncology and Health News

Oncology News: Quidel's QuickVue Influenza A+B test receives special 510(k) clearance for H1N1 rea.. http://bit.ly/1oErXK

3 years ago...

Advertisement